Home / Stocks / CAH

Cardinal Health (CAH, Health Care Distributors) Stock Valuation & Fair Value Trading above fair value

Cardinal Health (CAH, Health Care Distributors) trades at a blended P/E of 20.0, about 37% above its historical normal valuation, with a forward growth estimate of 11.5% and a PEG of 1.73. Analysts' one-year estimates have been hit 73% of the time.

DATA AS OF 2026-08-21
Blended P/E
20.0
Normal P/E
14.5
PEG
1.73
Fwd growth
11.5%
Div yield
0.9%
RSI (14)
46.4
Neutral

The Street vs SeerForecast

Wall Street's mean price target for CAH is $270.60 across 15 analysts, 17.9% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: trading above fair value. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been trading above fair value since 2026-06-03.

Price and rating by weekClose moved +20.3 percent from 2026-06-03 to 2026-08-17, with 3 rating changes over 21 recorded weeks.2026-06-03: Trading above fair value, close 195.42 (recalculated)2026-06-10: Trading above fair value, close 215.83 (recalculated)2026-06-14: Trading above fair value, close 223.36 (recalculated)2026-06-16: Trading above fair value, close 227.23 (recalculated)2026-06-21: Trading above fair value, close 221.29 (recalculated)2026-07-02: Significantly overvalued, close 238.94 (recalculated)2026-07-06: Significantly overvalued, close 237.52 (recalculated)2026-07-09: Significantly overvalued, close 233.77 (recalculated)2026-07-12: Significantly overvalued, close 235.80 (recalculated)2026-07-13: Significantly overvalued, close 233.66 (recalculated)2026-07-14: Significantly overvalued, close 230.11 (recalculated)2026-07-20: Significantly overvalued, close 225.75 (recalculated)2026-07-22: Significantly overvalued, close 220.54 (recalculated)2026-07-25: Significantly overvalued, close 228.03 (recalculated)2026-07-27: Significantly overvalued, close 229.35 (recalculated)2026-07-31: Significantly overvalued, close 230.03 (recalculated)2026-08-03: Significantly overvalued, close 230.032026-08-07: Significantly overvalued, close 236.40 (recalculated)2026-08-10: Significantly overvalued, close 236.402026-08-14: Trading above fair value, close 235.17 (recalculated)2026-08-17: Significantly overvalued, close 235.171952352026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 19.0+31%Trading above fair value
2026-06-10P/E 19.4+34%Trading above fair value
2026-06-14P/E 19.4+34%Trading above fair value
2026-06-16P/E 19.4+34%Trading above fair value
2026-06-21P/E 19.4+34%Trading above fair value
2026-07-02P/E 22.1+52%Significantly overvalued
2026-07-06P/E 22.2+53%Significantly overvalued
2026-07-09P/E 22.2+53%Significantly overvalued
2026-07-12P/E 21.8+50%Significantly overvalued
2026-07-13P/E 21.8+50%Significantly overvalued
2026-07-14P/E 21.8+50%Significantly overvalued
2026-07-20P/E 21.1+45%Significantly overvalued
2026-07-22P/E 21.1+45%Significantly overvalued
2026-07-25P/E 21.0+45%Significantly overvalued
2026-07-27P/E 21.0+45%Significantly overvalued
2026-07-31P/E 20.9+44%Significantly overvalued
2026-08-03P/E 21.1+46%Significantly overvalued
2026-08-07P/E 21.8+50%Significantly overvalued
2026-08-10P/E 21.7+49%Significantly overvalued
2026-08-14P/E 20.2+39%Trading above fair value
2026-08-17P/E 20.6+42%Significantly overvalued
2026-08-21P/E 20.0+37%Trading above fair value ← now

Frequently asked questions

Is Cardinal Health stock overvalued?

At a blended P/E of 20.0 versus its historical normal P/E of 14.5, Cardinal Health trades about 37% above its typical valuation, with a PEG of 1.73 on 11.5% forward growth. tickerseer currently rates it trading above fair value.

What is Cardinal Health's fair value and PEG?

Cardinal Health trades at a blended P/E of 20.0 against a historical normal P/E of 14.5, a PEG of 1.73, and a forward growth estimate of 11.5%.

Has tickerseer's rating of Cardinal Health changed?

tickerseer's rating has been trading above fair value since 2026-06-03.

What is the analyst price target for Cardinal Health?

The mean Wall Street price target for Cardinal Health is $270.60 across 15 analysts, 17.9% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Distributors. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track CAH free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.